ASIA-PACIFIC VETERINARY VACCINES MARKET 2022-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,500	115 Pages	Triton Market Research	May, 2022	TRTN17170465

Best Price Guarantee
Price	from $1,500
Length	115 Pages
Publisher	Triton Market Research
Published Date	May, 2022
SKU	TRTN17170465

Asia-pacific Veterinary Vaccines Market 2022-2028

MARKET OUTLOOK

Triton Market Research has estimated that the veterinary vaccines market in the Asia-Pacific region will advance at 8.79% CAGR during the forecasting years 2022 to 2028. Japan, India, China, Australia & New Zealand, South Korea, ASEAN Countries, and Rest of Asia-Pacific outline the market in the given region.

The Asia-Pacific offers lucrative opportunities for the veterinary vaccines market players. The focus of international players on investments, R&D, and manufacturing facilities enhances the importance of veterinary vaccines. Moreover, support from the government to control and eradicate animal disease has further boosted the market’s growth.

China is the 3rd largest country to have 95 million units of cattle. In this regard, it has emerged as the leading player in the veterinary vaccines market. Moreover, China is the largest pork producer globally, making it an important market for the veterinary manufacturing business. Also, the increasing livestock population in the country has escalated the demand for the vaccine business. Such factors have benefitted the growth of the veterinary vaccines market.

Similarly, India has the largest livestock population worldwide and ranks in the top 5 countries in aquaculture and global fish production. Animal husbandry is counted as one of the country’s major sources of economic growth, making it necessary for the country to preserve animal life. As a result, all these factors widen the growth of the veterinary vaccines market in India.

COMPETITIVE OUTLOOK

The leading companies in the veterinary vaccines market include Elanco Animal Health Inc, Boehringer Ingelheim International GmbH, Indian Immunologicals Limited, Merck Animal Health, Hipra, and Phibro Animal Health.

1. Asia-pacific Veterinary Vaccines Market – Summary
2. Industry Outlook: 2.1. Impact Of Covid-19 On The Veterinary Vaccines Market; 2.2. Key Insights; 2.2.1. Increasing Innovation By Market Participants; 2.2.2. Advancements In Vaccine And Diagnostic Technology; 2.3. Porter’s Five Forces Analysis; 2.3.1. Threat Of New Entrants; 2.3.2. Threat Of Substitutes; 2.3.3. Bargaining Power Of Buyers; 2.3.4. Bargaining Power Of Suppliers; 2.3.5. Threat Of Competitive Rivalry; 2.4. Market Attractiveness Index; 2.5. Value Chain Analysis; 2.6. Key Buying Criteria; 2.7. Regulatory Framework; 2.8. Vendor Scorecard; 2.9. Key Market Strategies; 2.9.1. Mergers & Acquisitions; 2.9.2. Contracts & Agreements; 2.9.3. Product Launches; 2.9.4. Expansions & Divestitures; 2.10. Market Drivers; 2.10.1. High Vaccine Demand Due To Increasing Animal Population And Diseases; 2.10.2. Government-organized Vaccination Drives; 2.10.3. Advanced Vaccine Research And Development; 2.11. Market Challenges; 2.11.1. Lack Of Awareness And Scarcity Of Skilled Veterinarians; 2.11.2. Stringent Rules And Regulations Pertaining To Vaccine Use; 2.12. Market Opportunities; 2.12.1. Expansion Of The Animal Healthcare Market In The Asia-pacific; 2.12.2. Rising Demand For Companion Animals
3. Asia-pacific Veterinary Vaccines Market Outlook – By Animal Type: 3.1. Livestock Animals; 3.1.1. Cattle; 3.1.2. Pigs; 3.1.3. Poultry; 3.1.4. Sheep; 3.1.5. Other Livestock Animals; 3.2. Companion Animals; 3.2.1. Canine; 3.2.2. Feline; 3.2.3. Equine; 3.3. Aquaculture
4. Asia-pacific Veterinary Vaccines Market Outlook – By Disease Type: 4.1. Canine Disease; 4.2. Porcine Disease; 4.3. Bovine Disease; 4.4. Poultry Disease; 4.5. Aquaculture Disease; 4.6. Other Disease Type
5. Asia-pacific Veterinary Vaccines Market Outlook – By Product Type: 5.1. Attenuated Vaccines; 5.2. Inactivated Vaccines; 5.3. Toxoid Vaccines; 5.4. Conjugate Vaccines; 5.5. Dna Vaccines; 5.6. Recombinant Vaccines; 5.7. Subunit Vaccines
6. Asia-pacific Veterinary Vaccines Market – Country Outlook: 6.1. China; 6.2. Japan; 6.3. India; 6.4. South Korea; 6.5. Asean Countries; 6.6. Australia & New Zealand; 6.7. Rest Of Asia-pacific
7. Competitive Landscape: 7.1. Boehringer Ingelheim International Gmbh; 7.2. Brilliant Bio Pharma; 7.3. Ceva Sante Animale; 7.4. Elanco Animal Health Inc; 7.5. Hester Biosciences Ltd; 7.6. Hipra; 7.7. Indian Immunologicals Limited; 7.8. Merck Animal Health; 7.9. Phibro Animal Health; 7.10. Vaxxinova Gmbh; 7.11. Virbac Sa; 7.12. Zoetis Inc
8. Research Methodology & Scope: 8.1. Research Scope & Deliverables; 8.2. Sources Of Data; 8.3. Research Methodology
Table List: Table 1: Asia-pacific Veterinary Vaccines Market, By Country, 2022-2028 (In $ Million); Table 2: Regulatory Framework; Table 3: Vendor Scorecard; Table 4: Asia-pacific Veterinary Vaccines Market, By Animal Type, 2022-2028 (In $ Million); Table 5: Asia-pacific Veterinary Vaccines Market, By Livestock Animals, 2022-2028 (In $ Million); Table 6: Asia-pacific Veterinary Vaccines Market, By Companion Animals, 2022-2028 (In $ Million); Table 7: Asia-pacific Veterinary Vaccines Market, By Disease Type, 2022-2028 (In $ Million); Table 8: Asia-pacific Veterinary Vaccines Market, By Product Type, 2022-2028 (In $ Million); Table 9: Asia-pacific Veterinary Vaccines Market, By Country Outlook, 2022-2028 (In $ Million)
Figure List: Figure 1: Market Attractiveness Index; Figure 2: Value Chain Analysis; Figure 3: Key Buying Criteria; Figure 4: Asia-pacific Veterinary Vaccines Market, By Animal Type, 2021 & 2028 (In %); Figure 5: Asia-pacific Veterinary Vaccines Market, By Livestock Animals, 2022-2028 (In $ Million); Figure 6: Asia-pacific Veterinary Vaccines Market, By Livestock Animals, 2021 & 2028 (In %); Figure 7: Asia-pacific Veterinary Vaccines Market, By Cattle, 2022-2028 (In $ Million); Figure 8: Asia-pacific Veterinary Vaccines Market, By Pigs, 2022-2028 (In $ Million); Figure 9: Asia-pacific Veterinary Vaccines Market, By Poultry, 2022-2028 (In $ Million); Figure 10: Asia-pacific Veterinary Vaccines Market, By Sheep, 2022-2028 (In $ Million); Figure 11: Asia-pacific Veterinary Vaccines Market, By Other Livestock Animals, 2022-2028 (In $ Million); Figure 12: Asia-pacific Veterinary Vaccines Market, By Companion Animals, 2022-2028 (In $ Million); Figure 13: Asia-pacific Veterinary Vaccines Market, By Companion Animals, 2021 & 2028 (In %); Figure 14: Asia-pacific Veterinary Vaccines Market, By Canine, 2022-2028 (In $ Million); Figure 15: Asia-pacific Veterinary Vaccines Market, By Feline, 2022-2028 (In $ Million); Figure 16: Asia-pacific Veterinary Vaccines Market, By Equine, 2022-2028 (In $ Million); Figure 17: Asia-pacific Veterinary Vaccines Market, By Aquaculture, 2022-2028 (In $ Million); Figure 18: Asia-pacific Veterinary Vaccines Market, By Disease Type, 2021 & 2028 (In %); Figure 19: Asia-pacific Veterinary Vaccines Market, By Canine Disease, 2022-2028 (In $ Million); Figure 20: Asia-pacific Veterinary Vaccines Market, By Porcine Disease, 2022-2028 (In $ Million); Figure 21: Asia-pacific Veterinary Vaccines Market, By Bovine Disease, 2022-2028 (In $ Million); Figure 22: Asia-pacific Veterinary Vaccines Market, By Poultry Disease, 2022-2028 (In $ Million); Figure 23: Asia-pacific Veterinary Vaccines Market, By Aquaculture Disease, 2022-2028 (In $ Million); Figure 24: Asia-pacific Veterinary Vaccines Market, By Other Disease Type, 2022-2028 (In $ Million); Figure 25: Asia-pacific Veterinary Vaccines Market, By Product Type, 2021 & 2028 (In %); Figure 26: Asia-pacific Veterinary Vaccines Market, By Attenuated Vaccines, 2022-2028 (In $ Million); Figure 27: Asia-pacific Veterinary Vaccines Market, By Inactivated Vaccines, 2022-2028 (In $ Million); Figure 28: Asia-pacific Veterinary Vaccines Market, By Toxoid Vaccines, 2022-2028 (In $ Million); Figure 29: Asia-pacific Veterinary Vaccines Market, By Conjugate Vaccines, 2022-2028 (In $ Million); Figure 30: Asia-pacific Veterinary Vaccines Market, By Dna Vaccines, 2022-2028 (In $ Million); Figure 31: Asia-pacific Veterinary Vaccines Market, By Recombinant Vaccines, 2022-2028 (In $ Million); Figure 32: Asia-pacific Veterinary Vaccines Market, By Subunit Vaccines, 2022-2028 (In $ Million); Figure 33: Asia-pacific Veterinary Vaccines Market, Country Outlook, 2021 & 2028 (In %); Figure 34: China Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 35: Japan Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 36: India Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 37: South Korea Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 38: Asean Countries Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 39: Australia & New Zealand Veterinary Vaccines Market 2022-2028 (In $ Million); Figure 40: Rest Of Asia-pacific Veterinary Vaccines Market 2022-2028 (In $ Million)